ADCs: How to manage complexities in growing supply chains
Upscaling the complex processes for bioconjugates manufacturing is now a necessity in the pharma industry as demand surges for innovative…
Partner Content
-
-
From friction to compliance: Cultivating seamless operations in a shifting regulatory landscape
2026 has brought a plethora of converging technological change and regulatory updates to the life sciences industry at an unprecedented…
-
Why Japan is a global destination for regenerative medicine
Through recent regulatory and policy reforms, Japan is becoming an increasingly attractive location for clinical research and development programmes, particularly…
-
Five considerations for adopting AI in clinical study build workflows
Artificial intelligence (AI) is becoming widely adopted in clinical data management, but the most persuasive use cases are rarely the…
-
Turning AI skeptics into AI advocates through high-integrity data
For years, biopharma has accumulated vast volumes of data. Now, as the industry races toward an AI-driven future, that data…
-
Biomarkers in Nephrology Research: From Exploratory to Decision-Making Tools
While strategic use of biomarkers in clinical trials has traditionally been associated with oncology, the potential for growth across other…
-
Annex 1 sterilisation: Why pharma packaging strategy is changing
The revised EU GMP Annex 1 has ushered in a new phase for sterile manufacturing. Published in 2022, with most…
-
Is your quality system built for 2026’s new regulatory reality?
The life sciences industry has always operated under pressure to stay ahead of regulatory change. But 2026 has raised the…
-
Keeping pace with generative AI in pharmaceutical and healthcare organisations
Increasingly, generative AI is transforming how that information is analysed, summarised and shared. According to 2026 research by the Copyright…
-
De-risking drug formulation with AI predictive modelling
Bringing a new drug to market is one of the most time‑consuming and costly assignments within the pharma industry. From…